Aojing Medical (688613.SH): Artificial bone repair material products obtained registration certificate in Thailand

Zhitongcaijing · 1d ago

Zhitong Finance App News, Aojing Medical (688613.SH) issued an announcement. The company submitted the registration application data for the company's artificial bone repair materials to the Thai Food and Drug Administration (TFDA) in May 2026. The company recently received a notice from the Food and Drug Administration of Thailand, and the company's artificial bone repair materials were approved.

The BonGold™ artificial bone repair material, which has obtained registration in Thailand this time, is a bionic mineralized collagen artificial bone repair material developed and produced based on in vitro bionic mineralization technology with completely independent intellectual property rights. It is highly bionic in terms of composition and microstructure. The product is used for bone defect repair without bone grafting contraindications in dentistry or orthopedic surgery. After implantation, it can be replaced by new bone tissue crawling while guiding bone regeneration. It is an implantable medical device product with good bone tissue regeneration and repair ability, and has broad clinical application potential and market space for various types of clinical bone defect repair.